UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: The nonsteroidal anti-inflammatory drugs in unstable angina treatment-2 (NUT-2) pilot study

Circulation (New York, N.Y.), 2002-07, Vol.106 (2), p.191-195

2002

Volltextzugriff (PDF)

Inflammatory and Prothrombotic Activation With Conserved Endothelial Function in Patients With Chronic, Asymptomatic Chagas Disease

Clinical and applied thrombosis/hemostasis, 2011-10, Vol.17 (5), p.502-507

2011

Volltextzugriff (PDF)

Diagnosis, Management, and Treatment of Chronic Chagas' Heart Disease in Areas Where Trypanosoma cruzi Infection Is Not Endemic

Revista española de cardiologia, 2007-03, Vol.60 (3), p.285-293

2007

Volltextzugriff (PDF)

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

European heart journal, 2016-10, Vol.37 (38), p.2882-2889

2016

Volltextzugriff (PDF)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

Heart (British Cardiac Society), 2017-02, Vol.103 (4), p.307-314

2017

Volltextzugriff (PDF)

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

PloS one, 2016-10, Vol.11 (10), p.e0164076-e0164076

2016

Volltextzugriff (PDF)

Prevalence of thyroid dysfunction in patients with type 2 diabetes mellitus

Medicina (Buenos Aires), 2016, Vol.76 (6), p.355-358

2016

Volltextzugriff (PDF)

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

PloS one, 2018-01, Vol.13 (1), p.e0191592-e0191592

2018

Volltextzugriff (PDF)

Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

The American heart journal, 2019-07, Vol.213, p.35-46

2019

Volltextzugriff (PDF)

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

BMJ open, 2017-12, Vol.7 (12), p.e017157-e017157

2017

Volltextzugriff (PDF)

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation

Circulation Cardiovascular quality and outcomes, 2015-03, Vol.8 (2 Suppl 1), p.S12-S20

2015

Volltextzugriff (PDF)

Takayasu's arteritis in a Caucasian man

Medicina (Buenos Aires), 2016, Vol.76 (4), p.252-252

2016

Volltextzugriff (PDF)

Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry

International journal of cardiology, 2016-11, Vol.223, p.543-547

2016

Volltextzugriff (PDF)

Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

The American journal of medicine, 2019-12, Vol.132 (12), p.1431-1440.e7

2019

Volltextzugriff (PDF)

Diagnostic role of new Doppler index in assessment of renal artery stenosis

Cardiovascular ultrasound, 2006-01, Vol.4 (1), p.4-4, Article 4

2006

Volltextzugriff (PDF)

Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry

Clinical cardiology (Mahwah, N.J.), 2019-05, Vol.42 (5), p.553-560

2019

Volltextzugriff (PDF)

Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry

BMJ open, 2017-03, Vol.7 (3), p.e014579

2017

Volltextzugriff (PDF)

Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry

Acta Cardiologica, 2019-07, Vol.74 (4), p.309-318

2019

Volltextzugriff (PDF)

Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)

European heart journal. Quality of care & clinical outcomes, 2018-01, Vol.4 (1), p.27-35

2018

Volltextzugriff (PDF)

Pheochromocytoma associated with von Recklinghausen neurofibromatosis

Medicina (Buenos Aires), 2007, Vol.67 (5), p.475-477

2007

Volltextzugriff (PDF)

Nocardia endocarditis in aortic and tricuspid native valves

Medicina (Buenos Aires), 2007, Vol.67 (3), p.279-281

2007

Volltextzugriff (PDF)

Pott disease in thoracic spine

Medicina (Buenos Aires), 2014, Vol.74 (5), p.391-391

2014

Volltextzugriff (PDF)

Facilitated Thrombolysis: Dethrombosis?

Clinical and applied thrombosis/hemostasis, 2002-04, Vol.8 (2), p.133-138

2002

Volltextzugriff (PDF)

Determination of blood markers and inflammation in subjects with impaired glucose tolerance

Archivos de cardiología de México, 2012-01, Vol.82 (1), p.1-6

2012

Volltextzugriff (PDF)

The prothrombotic state in early stages of chronic chagas' disease

Revista española de cardiologia, 2003-04, Vol.56 (4), p.377-382

2003

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(18)
Spanisch
(10)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: The nonsteroidal anti-inflammatory drugs in unstable angina treatment-2 (NUT-2) pilot study

Inflammatory and Prothrombotic Activation With Conserved Endothelial Function in Patients With Chronic, Asymptomatic Chagas Disease

Diagnosis, Management, and Treatment of Chronic Chagas' Heart Disease in Areas Where Trypanosoma cruzi Infection Is Not Endemic

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

Prevalence of thyroid dysfunction in patients with type 2 diabetes mellitus

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation

Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation

Takayasu's arteritis in a Caucasian man

Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry

Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF

Diagnostic role of new Doppler index in assessment of renal artery stenosis

Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry

Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry

Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry

Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF)

Pheochromocytoma associated with von Recklinghausen neurofibromatosis

Nocardia endocarditis in aortic and tricuspid native valves

Pott disease in thoracic spine

Facilitated Thrombolysis: Dethrombosis?

Determination of blood markers and inflammation in subjects with impaired glucose tolerance

The prothrombotic state in early stages of chronic chagas' disease

Aktive Filter

Suchergebnisse filtern